Clinical Trial Update: Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a peptide vaccine aimed at preventing recurrence in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• peptide vaccine

Snippet

Sponsor: Iwate Medical University | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN